This study is testing a new drug called NTX-2001 to see if it can help adults with Alcohol Use Disorder (AUD) reduce their alcohol consumption. Researchers also want to find out if NTX-2001 is safe and well-tolerated. You might be able to join if you are between 21 and 60 years old, speak English, and meet the criteria for AUD. The study will compare NTX-2001 to a placebo (a pill with no active drug). The main way they will measure success is by counting the number of drinks consumed over a two-week period. The current status of this study is unclear, and it plans to enroll about 50 participants.

Study design

This is an interventional study comparing NTX-2001 to a placebo. It plans to enroll about 50 participants.

What's involved

You would take NTX-2001 or a placebo every day for 2 weeks. You would also visit the clinic 4 times over a total of 10 weeks.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint measures alcohol consumption from Day 0 to Day 14.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.